Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index; none of the 31 sources its claims cite is checked for support yet.

Fabrication and antimicrobial properties of novel meropenem‐honey encapsulated chitosan nanoparticles against multiresistant and biofilm‐forming Staphylococcus aureus as a new antimicrobial agent

Open access
Hajimohammadi, Sameh, Momtaz, Hassan, Tajbakhsh, Elahe · 2024 · Veterinary Medicine and Science

Abstract

Background: Honey exhibits a broad spectrum of antibacterial activity against Gram‐positive and Gram‐negative bacteria, including methicillin‐resistant Staphylococcus aureus (MRSA) ones. Chitosan (Cs) is a mucoadhesive polymer that also has antibacterial properties. Special attention has been paid to the design of polymeric nanoparticles (NPs) as new nano drug delivery systems to overcome bacterial resistance and its problems. Objectives: The aim of the present study is to synthesize Cs‐meropenem NPs with/without honey as an antibiofilm and antibacterial agent to inhibit Staphylococcus aureus . Methods: This study synthesized meropenem and honey‐loaded Cs nanogels and subsequently characterized them by Field Emission Scanning Electron Microscopy (FESEM), Fourier Transform Infrared Spectroscopy (FTIR), and DLS‐zeta potential. Using the broth microdilution and crystal violet assays, the antibacterial and antibiofilm activity of meropenem and honey‐loaded Cs nanogel, free meropenem, free honey, and free Cs NPs were investigated in vitro against MRSA strains. 3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl‐2H‐tetrazolium bromide (MTT) was also used to test the cytotoxicity of several Cs‐NPs compound against the HEK‐293 regular cell line. Results: The average size of meropenem and honey‐Cs‐NPs was reported to be 119.885 nm, and encapsulation efficiency was 88.33 ± 0.97 with stability up to 60 days at 4°C. The NPs showed enhanced antibiofilm efficacy against S. aureus at sub‐minimum inhibitory concentrations. Additionally, the cytotoxicity of meropenem and honey‐encapsulated Cs against the HEK‐293 normal cell line was insignificant. Conclusions: Our findings suggested that meropenem and honey‐Cs‐NPs might be potential antibacterial and antibiofilm materials.

Overview

CoChat Summary

TL;DR

Meropenem and honey co-encapsulated in chitosan nanoparticles (C6) showed enhanced in vitro antibacterial/antibiofilm activity against multidrug-resistant, biofilm-forming *Staphylococcus aureus* and improved survival in a murine sepsis model. The formulation had high encapsulation efficiency, sustained release, and low cytotoxicity toward HEK-293 cells.

Key findings

  • The optimized C6 formulation (Cs + meropenem + honey) had a FESEM size of 119.885 nm, hydrodynamic diameter 266.2 ± 0.28 nm, PDI 0.118 ± 0.004, zeta potential +48.0 ± 1 mV, and encapsulation efficiency 88.33 ± 0.97%, with stability up to 60 days at 4°C.
  • Among 300 clinical samples, 106 (35.33%) were MRSA, 93/106 (87.73%) were MDR, 66/93 (70.96%) were vancomycin-resistant, and all 93 MDR isolates produced biofilm. C6 showed MIC 0.125–0.5 µg/mL, MBC 0.25–1.0 µg/mL, and MBIC 0.062–0.25 µg/mL across four selected strains, lower than free meropenem (MIC 2–4, MBC 4–8, MBIC 2–4 µg/mL).
  • C6 significantly reduced expression of biofilm-associated genes *ompA*, *pgaB*, and *Bap* (p < 0.00001) and was minimally toxic to HEK-293 cells at 256 µM (cell survival >70%), whereas free meropenem was toxic at 256 µM.
  • In a murine *S. aureus* sepsis model, C6-treated mice had 87.5% survival versus 12.5% for free meropenem, 50% for Cs + meropenem, and 0% for free Cs.

Methods

  • Chitosan nanoparticles with meropenem and/or honey were prepared in combinations C1–C6 and characterized by FESEM, FTIR, DLS/zeta potential, encapsulation efficiency, and in vitro release at pH 3.0, 5.0, and 7.4.
  • *S. aureus* was isolated from 300 patients (175 women, 125 men, average age 42 years) in Shahrekord hospitals during 2021–2022; susceptibility was tested by disk diffusion (CLSI), biofilm by Congo red/microtiter assays, MIC/MBC by broth microdilution, MBIC by crystal violet, biofilm gene expression by qRT-PCR, and cytotoxicity by MTT on HEK-293 cells.
  • In vivo, 42 female BALB/c mice (20–25 g, 6–8 weeks) were infected intraperitoneally with *S. aureus* (10⁷ CFU/mL) twice 2 weeks apart, divided into seven groups (six mice/cage), and treated with C1–C6 or control; survival, body weight, and clinical score were assessed.

Limitations

  • The paper states that chitosan has limited solubility in water and most organic solvents, restricting applicability, and that chitosan nanoparticles have constraints including cytotoxicity, degradability, and poor mechanical qualities; it also notes that further trials are required for effective field applications.
  • Evident from the text: in vitro antibacterial, antibiofilm, and gene-expression assays used only four selected clinical isolates plus ATCC 33592; the in vivo study used 42 mice (6/group) with short observation, and no pharmacokinetic, long-term toxicity, or mechanistic data are reported.
  • Evident from the text: some reported values are inconsistent, e.g., FESEM size 119.885 nm versus DLS hydrodynamic diameter 266.2 nm, and release described as 38% at 6 h and 60% within 120 h alongside 82%/72% initial burst in the first hour.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1002/vms3.1440

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIGURE 1 Field‐emission scanning electron microscopes of the prepared meropenem and honey chitosan‐nanoparticles (Cs‐NPs). The morphological features and surface appearance of Cs‐NPs were revealed by ESEM pictures. Meropenem‐honey Cs‐NPs have an almost spherical form, a smooth surface, and a size range of 119.885 nanometers. FSEM image of meropenem (A), FSEM image of meropenem and honey (B), FSEM image of Cs containing honey (C), FSEM image of Cs containing meropenem (D), and FSEM image of Cs encapsulated with meropenem and honey (E and F). ESEM, Environmental Scanning Electron Microscopy.
FIGURE 1 Field‐emission scanning electron microscopes of the prepared meropenem and honey chitosan‐nanoparticles (Cs‐NPs). The morphological features and surface appearance of Cs‐NPs were revealed by ESEM pictures. Meropenem‐honey Cs‐NPs have an almost spherical form, a smooth surface, and a size range of 119.885 nanometers. FSEM image of meropenem (A), FSEM image of meropenem and honey (B), FSEM image of Cs containing honey (C), FSEM image of Cs containing meropenem (D), and FSEM image of Cs encapsulated with meropenem and honey (E and F). ESEM, Environmental Scanning Electron Microscopy.CC BY-NC-ND · PubMed Central
FIGURE 2 Rates of drug release, and loading efficiency of different combinations of nanoparticles (NPs). (A) Data are shown as mean standard deviation (SD) for the in vitro release rate of meropenem and honey from chitosan (Cs)‐NPs at 37°C and pH 7.4; (B) effectiveness of C1–C6 combination of meropenem, meropenem + Cs, honey + Cs, and meropenem + honey Cs‐NPs. ***p < 0.001, **p < 0.01, *p < 0.05. ns, not significant. EE, encapsulation efficiency.
FIGURE 2 Rates of drug release, and loading efficiency of different combinations of nanoparticles (NPs). (A) Data are shown as mean standard deviation (SD) for the in vitro release rate of meropenem and honey from chitosan (Cs)‐NPs at 37°C and pH 7.4; (B) effectiveness of C1–C6 combination of meropenem, meropenem + Cs, honey + Cs, and meropenem + honey Cs‐NPs. ***p < 0.001, **p < 0.01, *p < 0.05. ns, not significant. EE, encapsulation efficiency.CC BY-NC-ND · PubMed Central
FIGURE 3 The micro‐pattern biofilm formation of MRSA and MDR strains‐isolated pathogens, when compared to controls (ATCC). The results are mentioned as the average of the OD value ± standard deviation (SD) from three independent experiments. ATCC, American Type Culture Collection; OD, Optical Density.
FIGURE 3 The micro‐pattern biofilm formation of MRSA and MDR strains‐isolated pathogens, when compared to controls (ATCC). The results are mentioned as the average of the OD value ± standard deviation (SD) from three independent experiments. ATCC, American Type Culture Collection; OD, Optical Density.CC BY-NC-ND · PubMed Central
FIGURE 4 Anti‐biofilm properties of various chitosan‐nanoparticles (Cs‐NPs). Biofilm growth suppression of different combinations Cs‐encapsulated. Data are mean ± SD. ***p < 0.000, ***p < 0.001, **p < 0.01, *p < 0.05. ns, not significant; OD, Optical Density.
FIGURE 4 Anti‐biofilm properties of various chitosan‐nanoparticles (Cs‐NPs). Biofilm growth suppression of different combinations Cs‐encapsulated. Data are mean ± SD. ***p < 0.000, ***p < 0.001, **p < 0.01, *p < 0.05. ns, not significant; OD, Optical Density.CC BY-NC-ND · PubMed Central
FIGURE 5 In response to C1–C6 chitosan formulations, mRNA expression of three important genes involved in biofilm formation (i.e., ompA, pgaB, and Bap) in all four isolates. Before (before the treatment of selected clinical strains with formulations C1 to C6) and after (after the treatment of selected clinical strains with formulations C1 to C6). Data are represented as mean ± SD. ***p < 0.000, ***p < 0.001, **p < 0.01, *p < 0.05. ns, not significant.
FIGURE 5 In response to C1–C6 chitosan formulations, mRNA expression of three important genes involved in biofilm formation (i.e., ompA, pgaB, and Bap) in all four isolates. Before (before the treatment of selected clinical strains with formulations C1 to C6) and after (after the treatment of selected clinical strains with formulations C1 to C6). Data are represented as mean ± SD. ***p < 0.000, ***p < 0.001, **p < 0.01, *p < 0.05. ns, not significant.CC BY-NC-ND · PubMed Central
FIGURE 6 Over the course of 24 h, cell viability percentages of HEK 293 cells treated with various combinations of chitosan (Cs)‐encapsulated meropenem and honey were compared to free meropenem. The results reflect the mean and standard deviation of three separate experiments. ***p < 0.001, **p < 0.01, *p < 0.0.5 were used as the significant levels.
FIGURE 6 Over the course of 24 h, cell viability percentages of HEK 293 cells treated with various combinations of chitosan (Cs)‐encapsulated meropenem and honey were compared to free meropenem. The results reflect the mean and standard deviation of three separate experiments. ***p < 0.001, **p < 0.01, *p < 0.0.5 were used as the significant levels.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

0 Valid · 2 Not valid · 31 Not checked · 85 Own results and interpretations

64 more claims

Create a free account to see all 118 claims and to verify the 26 references still open.

See all claims — free account
  • It may state two separate claims as one. 37
  • Probably not a substantial claim. 20
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

5 of 6 · the rest aren’t loaded

1 more finding

Create a free account to see every finding of this check.

See all findings — free account

Cited works that were retracted

Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.

2 of 2

Citations

Cites

2 retracted

Show all 52 references

Research works printed but not linked: 2

  1. CLSI, 2020, Performance standards for antimicrobial susceptibility testing; twenty‐second informational supplement (
  2. Riss T. L., 2004, Assay guidance manual [internet], 146

Metadata

Authors
Hajimohammadi, S., Momtaz, H., & Tajbakhsh, E.
Affiliations
Islamic Azad University of Shahrekord (IR)
Corresponding author
Momtaz, Hassan
Venue
Veterinary Medicine and Science
Publisher
Wiley
Published
2024-04-13
Volume
10
Issue
3
Pages
e1440-e1440
ISSN
2053-1095 (ISSN-L)
OpenAlex
W4394784240
Cited by
12
References
52
Citations by year
2026: 5 · 2025: 5 · 2024: 2
FWCI
1.70
Type
journal article
Language
en
Open access
Locations
  • Veterinary Medicine and Science (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Islamic Azad University, Shahrekord
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
  • Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
  • Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
Keywords
meropenem, honey, chitosan nanoparticles, nanogels, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, biofilm inhibition, antibacterial activity, multidrug resistance, drug delivery systems, encapsulation efficiency, cytotoxicity, HEK293 cells
MeSH terms
Meropenem, Animals, Anti-Infective Agents, Anti-Bacterial Agents, Gram-Negative Bacteria, Gram-Positive Bacteria, Honey, Humans, Staphylococcal Infections, Staphylococcus aureus, Biofilms, Chitosan, Nanoparticles, Methicillin-Resistant Staphylococcus aureus, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-11-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fabrication and antimicrobial properties of novel meropenem‐honey encapsulated chitosan nanoparticles against multiresistant and biofilm‐forming Staphylococcus aureus as a new antimicrobial agent. https://app.cochat.ai/papers/10.1002/vms3.1440
The paper
Hajimohammadi, S., Momtaz, H., & Tajbakhsh, E. (2024). Fabrication and antimicrobial properties of novel meropenem‐honey encapsulated chitosan nanoparticles against multiresistant and biofilm‐forming Staphylococcus aureus as a new antimicrobial agent. Veterinary Medicine and Science. https://doi.org/10.1002/vms3.1440

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.